Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Prashant A. Deshpande, Vivi M. Srivastava, Sathya Mani, Senthamizhselvi Anandhan, J. Meena, Aby Abraham, Auro Viswabandya, Biju George, Alok Srivastava, Vikram Mathews & Poonkuzhali Balasubramanian. (2016) Atypical BCR-ABL1 fusion transcripts in adult B-acute lymphoblastic leukemia, including a novel fusion transcript-e8a1. Leukemia & Lymphoma 57:10, pages 2481-2484.
Read now
Read now
Elena Maino, Rosaria Sancetta, Piera Viero, Silvia Imbergamo, Anna Maria Scattolin, Michele Vespignani & Renato Bassan. (2014) Current and future management of Ph/BCR-ABL positive ALL. Expert Review of Anticancer Therapy 14:6, pages 723-740.
Read now
Read now
Michael S. Mathisen, Hagop Kantarjian, Deborah Thomas, Susan O’Brien & Elias Jabbour. (2013) Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates. Leukemia & Lymphoma 54:12, pages 2592-2600.
Read now
Read now
Alexandra Böhm, Harald Herrmann, Gerlinde Mitterbauer-Hohendanner, Alexander W Hauswirth, Werner Rabitsch, Margit Mitterbauer, Wolfgang R Sperr, Peter Kalhs, Ulrich Jäger & Peter Valent. (2011) Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ‘pre-leukemic’ stem cells?. Leukemia & Lymphoma 52:5, pages 842-848.
Read now
Read now
Yenan Li, Dehui Zou, Yaozhong Zhao, Yingchang Mi, Jianxiang Wang & Lugui Qiu. (2010) Clinical characteristics and outcomes of adults with Philadelphia chromosome positive and/or bcr-abl positive acute lymphoblastic leukemia: a single center study from China. Leukemia & Lymphoma 51:3, pages 488-496.
Read now
Read now
Shaoguang Li. (2008) Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. Leukemia & Lymphoma 49:1, pages 19-26.
Read now
Read now
Kimbach T Carpiuc, Jennifer M Stephens, Marc F Botteman, Weiwei Feng & Joel W Hay. (2007) A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia. Expert Opinion on Pharmacotherapy 8:16, pages 2775-2787.
Read now
Read now
Yesid Alvarado, Effrosyni Apostolidou, Ronan Swords & Francis J Giles. (2007) Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemia. Expert Opinion on Emerging Drugs 12:1, pages 165-179.
Read now
Read now
Giovanni Reddiconto, Patrizia Chiusolo, Alessia Fiorini, Giuliana Farina, Federica Sorà, Giuseppe Leone & Simona Sica. (2007) Dasatinib restores full donor chimerism in a patient with imatinib-resistant Ph+ ALL relapsing after unrelated cord blood transplantation. Leukemia & Lymphoma 48:10, pages 2054-2057.
Read now
Read now
Masamitsu Yanada & Tomoki Naoe. (2006) Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: Major challenges in current practice. Leukemia & Lymphoma 47:9, pages 1747-1753.
Read now
Read now
Xavier Thomas. (2005) Emerging drugs for adult acute lymphoblastic leukaemia. Expert Opinion on Emerging Drugs 10:3, pages 591-617.
Read now
Read now
Roch Houot, Emmanuelle Tavernier, Quoc-Hung Le, Véronique Lhéritier, Anne Thiebaut & Xavier Thomas. (2004) Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in the Elderly: Prognostic Factors and Treatment Outcome. Hematology 9:5-6, pages 369-376.
Read now
Read now
Articles from other publishers (102)
Josep-Maria Ribera, Thibaud Prawitz, Andreas Freitag, Anuj Sharma, Balázs Dobi, Federica Rizzo, Lorenzo Sabatelli & Petros Patos. (2023) Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison. Advances in Therapy 40:7, pages 3087-3103.
Crossref
Crossref
Zulfa Omer & Emily Curran. (2023) Moving Toward a Chemotherapy-Free Approach for Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia. Advances in Oncology 3:1, pages 107-116.
Crossref
Crossref
Yuichi Sameshima, Michiko Okada, Masayuki Shiseki, Naoki Mori, Toshiko Motoji & Junji Tanaka. (2023) Establishment and Characterization of an Acute Lymphocytic Leukemia Cell Line Expressing CD13 and CD33 with a Complex Philadelphia Translocation. Internal Medicine 62:5, pages 697-701.
Crossref
Crossref
小飞 杜. (2023) Progress in the Treatment of Philadelphia Chromosome Positive Acute Lymphocytic Leukemia. Advances in Clinical Medicine 13:03, pages 3581-3588.
Crossref
Crossref
Xiaofeng Wu, Anton B. Iliuk & W. Andy Tao. 2023.
119
153
.
Alessandra Fallati, Noemi Di Marzo, Giovanna D’Amico & Erica Dander. (2022) Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche. Cancers 14:14, pages 3303.
Crossref
Crossref
Bohan Ma, Hui Feng, Chao Feng, Yi Liu, Hailing Zhang, Jincheng Wang, Wenjuan Wang, Pengcheng He & Fan Niu. (2022) Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia. Advanced Science 9:13.
Crossref
Crossref
Giovanni MartinelliCristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. LemoliFabio Guolo, Antonella FornaroMonia LunghiPaolo de FabritiisAnna CandoniCarmine SelleriFederico SimonettiMonica Bocchia, Antonella VitaleLuca Frison, Alessandra TedeschiAntonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’ArdiaSilvia TrappoliniPatrizia TosiPiero GalieniFrancesco FabbianoMaria Chiara AbbenanteMuriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara SartorStefania PaoliniMichele CavoRobin FoàPaola FaziMarco Vignetti & Michele Baccarani. (2022) INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia. Blood Advances 6:6, pages 1742-1753.
Crossref
Crossref
HawarGhareb Khudhur, KawaMuhamadamin Hasan, RananKardagh Polus, AhmedKhudair Yassin, NawsherwanSadiq Mohammad & SayaSalahaldeen Najmaldeen. (2022) Outcome of adult acute lymphoblastic leukemia, a single-center experience. Iraqi Journal of Hematology 11:2, pages 151.
Crossref
Crossref
Richard T. Maziarz & Gerhard C. Hildebrandt. 2021. Blood and Marrow Transplant Handbook. Blood and Marrow Transplant Handbook
251
270
.
Alexander Gavralidis & Andrew M. Brunner. (2020) Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 15:4, pages 294-304.
Crossref
Crossref
Zabih Warraich, Pavan Tenneti, Theresa Thai, Anne Hubben, Hina Amin, Ali McBride, Sami Warraich, Abdul Hannan, Faiza Warraich, Navneet Majhail, Matt Kalaycio & Faiz Anwer. (2020) Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review. Biology of Blood and Marrow Transplantation 26:3, pages e55-e64.
Crossref
Crossref
Avinash Pandey, Shivali Ahlawat, Anjana Singh, Shivkant Singh, Krishna Murari & Raj Aryan. (2020) Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol. Cancer Research, Statistics, and Treatment 3:2, pages 183.
Crossref
Crossref
Poonam Jain, Jun Gu, Rashmi Kanagal-Shamanna, Zhenya Tang, Keyur P. Patel, Hui Yao, Lianghua Fang, Hai-Yan Bao, Ching-Hua Liu, Pei Lin, L.Jeffrey Medeiros & Xinyan Lu. (2019) Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens. Leukemia Research 84, pages 106176.
Crossref
Crossref
Justine Arrington, Liang Xue, Wen-Horng Wang, Robert L. Geahlen & W. Andy Tao. (2019) Identification of the Direct Substrates of the ABL Kinase via Kinase Assay Linked Phosphoproteomics with Multiple Drug Treatments. Journal of Proteome Research 18:4, pages 1679-1690.
Crossref
Crossref
Renata Virgínia Cavalcanti Santos, Wanessa Layssa Batista de Sena, Flaviana Alves dos Santos, Antônio Felix da Silva Filho, Marina Galdino da Rocha Pitta, Maira Galdino da Rocha Pitta, Moacyr Barreto de Melo Rego & Michelly Cristiny Pereira. (2019) Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?. Current Drug Targets 20:6, pages 635-654.
Crossref
Crossref
Muhammad Waqas Khan, Ahmed Elmaaz & Zartash Gul. 2018. Stem Cells in Clinical Practice and Tissue Engineering. Stem Cells in Clinical Practice and Tissue Engineering.
Francesco Corrente, Silvia Bellesi, Elisabetta Metafuni, Pier Luigi Puggioni, Sara Marietti, Angela Maria Ciminello, Tommaso Za, Federica Sorà, Luana Fianchi, Simona Sica, Valerio De Stefano & Patrizia Chiusolo. (2018)
Role of flow-cytometric immunophenotyping in prediction of
BCR/ABL1
gene rearrangement in adult B-cell acute lymphoblastic leukemia
. Cytometry Part B: Clinical Cytometry 94:3, pages 468-476.
Crossref
Crossref
T Terwilliger & M Abdul-Hay. (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer Journal 7:6, pages e577-e577.
Crossref
Crossref
Barbara J. Bain. 2017. Leukaemia Diagnosis. Leukaemia Diagnosis
249
294
.
Pu Chen, Andrew Chu, Hamid Zia, Prasad Koduru, Robert Collins, Naomi Winick, Franklin Fuda & Weina Chen. (2016) CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative Patients. American Journal of Clinical Pathology 146:5, pages 632-638.
Crossref
Crossref
Shilpa Paul, Hagop Kantarjian & Elias J. Jabbour. (2016) Adult Acute Lymphoblastic Leukemia. Mayo Clinic Proceedings 91:11, pages 1645-1666.
Crossref
Crossref
Leonard Sender & Keri B. Zabokrtsky. (2015) Adolescent and young adult patients with cancer: a milieu of unique features. Nature Reviews Clinical Oncology 12:8, pages 465-480.
Crossref
Crossref
Walid AL-Achkar, Abdulsamad Wafa, Moneeb Abdullah Kassem Othman, Faten Moassass, Abdulmunim Aljapawe & Thomas Liehr. (2014) An adult B-cell precursor acute lymphoblastic leukemia with multiple secondary cytogenetic aberrations. Molecular Cytogenetics 7:1.
Crossref
Crossref
Ohad Benjamini, Theresa Liu Dumlao, Hagop Kantarjian, Susan O'Brien, Guillermo Garcia-Manero, Stefan Faderl, Jeffrey Jorgensen, Rajyalakshmi Luthra, Rebecca Garris, Deborah Thomas, Partow Kebriaei, Richard Champlin, Elias Jabbour, Jan Burger, Jorge Cortes & Farhad Ravandi. (2014) Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia. American Journal of Hematology 89:3, pages 282-287.
Crossref
Crossref
Marco Vignetti, Paola Fazi, Andrea la Sala & Franco Mandelli. (2014) Treatment of Philadelphia-positive acute lymphoid leukemia. International Journal of Hematologic Oncology 3:1, pages 71-83.
Crossref
Crossref
Amir Behdad, Bryan L. Betz, Megan S. Lim & Nathanael G. Bailey. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer
135
167
.
A. K. Fielding & G. A. Zakout. (2013) Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 8:2, pages 98-108.
Crossref
Crossref
Milena Todorovic, Ziv Radisavljevic, Bela Balint, Bosko Andjelic, Vera Todorovic, Maja Perunicic Jovanovic & Biljana Mihaljevic. (2012) Increased Angiogenesis-associated Poor Outcome in Acute Lymphoblastic Leukemia. Applied Immunohistochemistry & Molecular Morphology 20:5, pages 488-493.
Crossref
Crossref
Theresa Liu-Dumlao, Hagop Kantarjian, Deborah A. Thomas, Susan O’Brien & Farhad Ravandi. (2012) Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options. Current Oncology Reports 14:5, pages 387-394.
Crossref
Crossref
Wei-Gang Tong, Zeev Estrov, Yongtao Wang, Susan O’Brien, Stefan Faderl, David M. Harris, Quin Van Pham, Inbal Hazan-Halevy, Zhiming Liu, Patricia Koch, Hagop Kantarjian, Michael J. Keating & Alessandra Ferrajoli. (2010) The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells. Investigational New Drugs 29:6, pages 1206-1212.
Crossref
Crossref
Michael S. Mathisen, Susan O’Brien, Deborah Thomas, Jorge Cortes, Hagop Kantarjian & Farhad Ravandi. (2011) Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 6:3, pages 187-194.
Crossref
Crossref
Jesse Jaso, Deborah A. Thomas, Krista Cunningham, Jeffrey L. Jorgensen, Hagop M. Kantarjian, L. Jeffrey Medeiros & Sa A. Wang. (2011) Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors. Cancer 117:17, pages 4009-4017.
Crossref
Crossref
Christy J. Stotler & Edward Copelan. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
305
313
.
Deborah A. Thomas, Susan O’Brien, Stefan Faderl & Hagop Kantarjian. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
233
255
.
Heather O’Leary, Stephen M. Akers, Debra Piktel, Cheryl Walton, James E. Fortney, Karen H. Martin, Michael Craig, James Coad & Laura F. Gibson. (2010) VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis. Cancer Microenvironment 3:1, pages 67-81.
Crossref
Crossref
Olga Sala‐Torra & Jerald P. Radich. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy
228
243
.
X. Thomas, G. Cannas, Y. Chelghoum & A. Gougounon. (2010) Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte. Bulletin du Cancer 97:9, pages 1105-1117.
Crossref
Crossref
Barbara J. Bain. 2010. Leukaemia Diagnosis. Leukaemia Diagnosis
114
218
.
Markus Lindauer & Andreas Hochhaus. 2010. Small Molecules in Oncology. Small Molecules in Oncology
83
102
.
Yenan Li, Lugui Qiu, Dehui Zou, Yaozhong Zhao, Yingchang Mi & Jianxiang Wang. (2009) Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Annals of Hematology 88:11, pages 1069-1077.
Crossref
Crossref
Farhad Ravandi & Partow Kebriaei. (2009) Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 23:5, pages 1043-1063.
Crossref
Crossref
Ilaria IacobucciClelia Tiziana StorlazziDaniela CilloniAnnalisa LonettiEmanuela OttavianiSimona SoveriniAnnalisa AstolfiSabina ChiarettiAntonella VitaleFrancesca MessaLuciana ImperaCarmen BaldazziPietro D'AddabboCristina PapayannidisAngelo LonoceSabrina ColarossiMarco VignettiPier Paolo PiccalugaStefania PaoliniDomenico Russo, Fabrizio Pane, Giuseppe SaglioMichele BaccaraniRobin FoàGiovanni Martinelli. (2009) Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1–positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 114:10, pages 2159-2167.
Crossref
Crossref
Adele K. FieldingJacob M. RoweSusan M. RichardsGeorgina BuckAnthony V. MoormanI. Jill DurrantDavid I. MarksAndrew K. McMillanMark R. LitzowHillard M. LazarusLetizia ForoniGordon DewaldIan M. FranklinSelina M. LugerElisabeth PaiettaPeter H. WiernikMartin S. Tallman & Anthony H. Goldstone. (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood 113:19, pages 4489-4496.
Crossref
Crossref
Liming Bao, Sherilyn A. Gross, John Ryder, Xiaoqin Wang, Meirong Ji, Yan Chen, Yongchen Yang, Saijuan Zhu & Richard D. Irons. (2009) Adult precursor B lymphoblastic leukemia in Shanghai, China: characterization of phenotype, cytogenetics and outcome for 137 consecutive cases. International Journal of Hematology 89:4, pages 431-437.
Crossref
Crossref
F Passetti, C G Ferreira & F F Costa. (2009) The impact of microRNAs and alternative splicing in pharmacogenomics. The Pharmacogenomics Journal 9:1, pages 1-13.
Crossref
Crossref
Ryuzo Ohno. (2008) Treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Current Oncology Reports 10:5, pages 379-387.
Crossref
Crossref
Ginna G. Laport, Joseph C. Alvarnas, Joycelynne M. Palmer, David S. Snyder, Marilyn L. Slovak, Athena M. Cherry, Ruby M. Wong, Robert S. Negrin, Karl G. Blume & Stephen J. Forman. (2008) Long-term remission of Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation–etoposide regimen. Blood 112:3, pages 903-909.
Crossref
Crossref
Marissa Shrader & Jorge E. Cortés. (2008) Highlights from the 49th Annual Meeting of the American Society of Hematology: Atlanta, GA; December 8–11, 2007. Clinical Leukemia 2:2, pages 89-95.
Crossref
Crossref
A K Fielding & A H Goldstone. (2007) Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplantation 41:5, pages 447-453.
Crossref
Crossref
Meir Wetzler & Kryzstof Mrózek. 2008. Acute Leukemias. Acute Leukemias
95
108
.
Stefan H. Faderl & Hagop Kantarjian. 2008. Acute Leukemias. Acute Leukemias
237
246
.
Olga Sala-Torra & Jerald P. Radich. 2008. Acute Leukemias. Acute Leukemias
177
189
.
S. Faderl, D. A. Thomas & Hagop M. Kantarjian. 2008. Acute Leukemias. Acute Leukemias
161
166
.
Pier Paolo Piccaluga, Stefania Paolini & Giovanni Martinelli. (2007) Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer 110:6, pages 1178-1186.
Crossref
Crossref
Tianjun Zhou, Lois Parillon, Feng Li, Yihan Wang, Jeff Keats, Sarah Lamore, Qihong Xu, William Shakespeare, David Dalgarno & Xiaotian Zhu. (2007) Crystal Structure of the T315I Mutant of Abl Kinase. Chemical Biology & Drug Design 70:3, pages 171-181.
Crossref
Crossref
Deborah A. Thomas, Susan O’Brien, Jorge Cortes & Hagop Kantarjian. (2007) New approaches to the management of Philadelphia chromosome-positive acute lymphocytic leukemia. Current Hematologic Malignancy Reports 2:3, pages 183-189.
Crossref
Crossref
Effrosyni Apostolidou, Ronan Swords, Yesid Alvarado & Francis J Giles. (2007) Treatment of Acute Lymphoblastic Leukaemia. Drugs 67:15, pages 2153-2171.
Crossref
Crossref
Deborah A. Thomas. (2007) Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia: A New Era of Challenges. Hematology 2007:1, pages 435-443.
Crossref
Crossref
Jorge E. Cortés, Alfonso Quintás-Cardama & Hagop Kantarjian. (2006) Challenges and Progress in the Treatment of Adults with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Clinical Leukemia 1:1, pages 19-27.
Crossref
Crossref
Ryuzo Ohno. (2006) Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. Current Hematologic Malignancy Reports 1:3, pages 180-187.
Crossref
Crossref
John S. Tokarski, John A. Newitt, Chieh Ying J. Chang, Janet D. Cheng, Michael Wittekind, Susan E. Kiefer, Kevin Kish, Francis Y.F. Lee, Robert Borzillerri, Louis J. Lombardo, Dianlin Xie, Yaqun Zhang & Herbert E. Klei. (2006) The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants. Cancer Research 66:11, pages 5790-5797.
Crossref
Crossref
A. Wrzesień-Kuś, T. Robak, A. Pluta, M. Zwolińska, E. Wawrzyniak, A. Wierzbowska, A. Skotnicki, B. Jakubas, J. Hołowiecki, K. Nowak, K. Kuliczkowski, G. Mazur, O. Haus, A. Dmoszyńska, M. Adamczyk-Cioch, W. W. Jędrzejczak, M. Paluszewska, L. Konopka & G. Pałynyczko. (2006) Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR–ABL-positive acute lymphoblastic leukemia—retrospective analysis of Polish Adult Leukemia Group (PALG). Annals of Hematology 85:6, pages 366-373.
Crossref
Crossref
Livio PaganoMorena CairaLuana FianchiGiuseppe Leone. (2006) Acute lymphoblastic leukemia in elderly patients: clinical characteristics, treatment and outcome. Aging Health 2:1, pages 123-133.
Crossref
Crossref
Masamitsu YanadaJin TakeuchiIsamu SugiuraHideki AkiyamaNoriko UsuiFumiharu YagasakiTohru KobayashiYasunori UedaMakoto TakeuchiShuichi MiyawakiAtsuo MarutaNobuhiko EmiYasushi MiyazakiShigeki OhtakeItsuro JinnaiKeitaro MatsuoTomoki NaoeRyuzo Ohno. (2006)
High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed
BCR
-
ABL
–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group
. Journal of Clinical Oncology 24:3, pages 460-466.
Crossref
Crossref
Lene Hyldahl Olesen, Niels Clausen, Andreja Dimitrijevic, Gitte Kerndrup, Eigil Kjeldsen & Peter Hokland. (2004) Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. British Journal of Haematology 127:1, pages 59-66.
Crossref
Crossref
Natasa Kukoc-Zivojnov, Elena Puccetti, Kai U Chow, Marion Bergmann, Martin Ruthardt, Dieter Hoelzer, Paris S Mitrou, Eckhart Weidmann & Simone Boehrer. (2004) Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185BCR-ABL in hematopoietic cells. Experimental Hematology 32:7, pages 649-656.
Crossref
Crossref
Renato Bassan, Gemma Gatta, Carlo Tondini & Roel Willemze. (2004) Adult acute lymphoblastic leukaemia. Critical Reviews in Oncology/Hematology 50:3, pages 223-261.
Crossref
Crossref
Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, Carleton C. Stewart, Andrew J. Carroll, Ramana Tantravahi, James W. Vardiman, Richard A. Larson & Clara D. Bloomfield. (2004) Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B. British Journal of Haematology 124:3, pages 275-288.
Crossref
Crossref
Tadeusz Robak. (2004) Acute Lymphoblastic Leukaemia in Elderly Patients. Drugs & Aging 21:12, pages 779-791.
Crossref
Crossref
Chirayu Udomsakdi-Auewarakul, Orathai Promsuwicha, Chintana Tocharoentanaphol, Chanya Munhketvit, Kovit Pattanapanyasat & Surapol Issaragrisil. (2018) Immunophenotypes and Outcome of Philadelphia Chromosome-Positive and -Negative Thai Adult Acute Lymphoblastic Leukemia. International Journal of Hematology 78:4, pages 337-343.
Crossref
Crossref
B Wassmann, U Scheuring, H Pfeifer, A Binckebanck, A Käbisch, M Lübbert, L Leimer, H Gschaidmeier, D Hoelzer & O G Ottmann. (2003) Efficacy and safety of imatinib mesylate (Glivec™) in combination with interferon-α (IFN-α) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Leukemia 17:10, pages 1919-1924.
Crossref
Crossref
U J Scheuring, H Pfeifer, B Wassmann, P Brück, B Gehrke, E K Petershofen, H Gschaidmeier, D Hoelzer & O G Ottmann. (2003) Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment. Leukemia 17:9, pages 1700-1706.
Crossref
Crossref
H Espérou, J-M Boiron, J-M Cayuela, O Blanchet, M Kuentz, J-P Jouet, N Milpied, J-Y Cahn, C Faucher, J-H Bourhis, M Michallet, M-L Tanguy, J-P Vernant, J Gabert, P Bordigoni, N Ifrah, A Baruchel & H Dombret. (2003) A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Bone Marrow Transplantation 31:10, pages 909-918.
Crossref
Crossref
S Tauro, D McMullan, M Griffiths, C Craddock & P Mahendra. (2003) High-hyperdiploidy in Philadelphia positive adult acute lymphoblastic leukaemia: case-series and review of literature. Bone Marrow Transplantation 31:9, pages 763-766.
Crossref
Crossref
I Avivi & A H Goldstone. (2003) Bone marrow transplant in Ph+ ALL patients. Bone Marrow Transplantation 31:8, pages 623-632.
Crossref
Crossref
Apostolia M. Tsimberidou, Hagop M. Kantarjian, Jorge Cortes, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia‐Manero, Srdan Verstovsek, Alessandra Ferrajoli, William Wierda, Yesid Alvarado, Susan M. O'Brien, Maher Albitar, Michael J. Keating & Francis J. Giles. (2003) Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte‐macrophage–colony stimulating factor (GM‐CSF) alternating with methotrexate and cytarabine plus rituximab and GM‐CSF in patients with Richter syndrome or fludarabine‐refractory chronic lymphocytic leukemia. Cancer 97:7, pages 1711-1720.
Crossref
Crossref
Blanca Sanchez-GonzalezJose C. Pascual-RamirezPascual Fernandez-AbellanIsabel Belinchon-RomeroConcepcion RivasGloria Vegara-Aguilera. (2003) Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia. Blood 101:6, pages 2446-2446.
Crossref
Crossref
Mireille Guimarães Vaz de Campos, Maria de Lourdes L. Ferrari Chauffaille, Celso Arrais Rodrigues, Everson A. Krum & Mihoko Yamamoto. (2003) A rare case of Acute Lymphocytic Leukemia (ALL) presenting with double Philadelphia chromosome: relapse or secondary leukemia?. Genetics and Molecular Biology 26:3, pages 249-251.
Crossref
Crossref
Harald Rieder & Michael Kneba. 2003. Molekularmedizinische Grundlagen von hämatologischen Neoplasien. Molekularmedizinische Grundlagen von hämatologischen Neoplasien
370
389
.
Deborah A Thomas, Jorge Cortes & Hagop M Kantarjian. (2002) New agents in the treatment of acute lymphocytic leukaemia. Best Practice & Research Clinical Haematology 15:4, pages 771-790.
Crossref
Crossref
Oliver G Ottmann & Barbara Wassmann. (2002) Imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia: current status and evolving concepts. Best Practice & Research Clinical Haematology 15:4, pages 757-769.
Crossref
Crossref
Manisha Bhutani, Lalit Kumar, Amish Vora, Narendra Bhardwaj, Ashutosh Kumar Pathak, Rajvir Singh & Vinod Kochupillai. (2002) Randomized study comparing 4′‐epi‐doxorubicin (Epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia. American Journal of Hematology 71:4, pages 241-247.
Crossref
Crossref
Giovanni Cazzaniga, Marina Lanciotti, Vincenzo Rossi, Daniela Di Martino, Maurizio Aricò, Maria Grazia Valsecchi, Giuseppe Basso, Giuseppe Masera, Concetta Micalizzi & Andrea Biondi. (2002)
Prospective molecular monitoring of BCR/ABL transcript in children with Ph
+
acute lymphoblastic leukaemia unravels differences in treatment response
. British Journal of Haematology 119:2, pages 445-453.
Crossref
Crossref
Martin S Tallman. (2002) Advancing the treatment of hematologic malignancies through the development of targeted interventions. Seminars in Hematology 39:4, pages 1-5.
Crossref
Crossref
J Takeuchi, T Kyo, K Naito, H Sao, M Takahashi, S Miyawaki, K Kuriyama, S Ohtake, F Yagasaki, H Murakami, N Asou, T Ino, T Okamoto, N Usui, M Nishimura, K Shinagawa, T Fukushima, H Taguchi, T Morii, S Mizuta, H Akiyama, Y Nakamura, T Ohshima & R Ohno. (2002) Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia 16:7, pages 1259-1266.
Crossref
Crossref
O Hrušák & A Porwit-MacDonald. (2002) Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 16:7, pages 1233-1258.
Crossref
Crossref
Stefan Faderl, Guillermo Garcia‐Manero, Deborah A. Thomas & Hagop M. Kantarjian. (2002) Philadelphia chromosome‐positive acute lymphoblastic leukemia– current concepts and future perspectives. Reviews in Clinical and Experimental Hematology 6:2, pages 142-160.
Crossref
Crossref
Xavier Thomas. (2002) Nouvelles approches thérapeutiques des leucémies aiguës de l'adulte. Revue Française des Laboratoires 2002:344, pages 55-65.
Crossref
Crossref
N.L. Ramakers‐van Woerden, R. Pieters, D. Hoelzer, R.M. Slater, M.L. den Boer, A.H. Loonen, J. Harbott, G.E. Janka‐Schaub, W‐D Ludwig, G.J. Ossenkoppele, E.R. van Wering & A.J.P. Veerman. (2002) In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: A report of the Dutch and German Leukemia Study Groups. Medical and Pediatric Oncology 38:6, pages 379-386.
Crossref
Crossref
Jerald P. Radich. (2002) Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology 15:1, pages 91-103.
Crossref
Crossref
Anja ReichertNora HeisterkampGeorge Q. DaleyJohn Groffen. (2001) Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336. Blood 97:5, pages 1399-1403.
Crossref
Crossref
MD Tabernero, AM Bortoluci, I Alaejos, MC López-Berges, A Rasillo, R García-Sanz, M García, JM Sayagués, M González, G Mateo, JF San Miguel & A Orfao. (2001) Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression. Leukemia 15:3, pages 406-414.
Crossref
Crossref
Hagop M. Kantarjian. (2001) Adult Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, pages 207-211.
Crossref
Crossref
Thomas G. Martin & Charles A. Linker. (2001) Autologous Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America 15:1, pages 121-143.
Crossref
Crossref
Thomas G. Martin & James L. Gajewski. (2001) Allogeneic Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America 15:1, pages 97-120.
Crossref
Crossref
Jerald P. Radich. (2001) Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia. Hematology/Oncology Clinics of North America 15:1, pages 21-36.
Crossref
Crossref
Guillermo Garcia-Manero & Hagop M. Kantarjian. (2000) THE HYPER-CVAD REGIMEN IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA. Hematology/Oncology Clinics of North America 14:6, pages 1381-1396.
Crossref
Crossref
Stefan Faderl & Maher Albitar. (2000) INSIGHTS INTO THE BIOLOGIC AND MOLECULAR ABNORMALITIES IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA. Hematology/Oncology Clinics of North America 14:6, pages 1267-1288.
Crossref
Crossref
Meir Wetzler. (2000) CYTOGENETICS IN ADULT ACUTE LYMPHOCYTIC LEUKEMIA. Hematology/Oncology Clinics of North America 14:6, pages 1237-1249.
Crossref
Crossref
Adolfo A Ferrando & A.Thomas Look. (2000) Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Seminars in Hematology 37:4, pages 381-395.
Crossref
Crossref
Peter Hokland & Niels Pallisgaard. (2000) Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia. Seminars in Hematology 37:4, pages 358-367.
Crossref
Crossref